Our Stories

Gerald Joyce elected to Royal Swedish Academy of S..
Gerald Joyce, a pioneer in the field of directed evolution, has been elected to the prestigious Royal Swedish Academy of Sciences as a foreign member of the Academy’s Class for Chemistry.

Embracing big data to understand complex diseases..
Researchers discover that networks of proteins circulating in the blood influence the development and progression of chronic diseases

Minion challenges assumptions about the genome..
Minion challenges assumptions about the genome

Experimental treatment clears malaria infections i..
Compound offers a potential tool for fighting drug-resistant malaria parasites.

Counting on combos for complex liver diseases..
The best treatment for multifaceted diseases like NASH may be combinations of drugs.

Gerald Joyce elected to Royal Swedi..

Embracing big data to understand co..

Minion challenges assumptions about..

Experimental treatment clears malar..

Counting on combos for complex live..
Our Research
General Medical Biology
Biotherapeutics & Biotechnology
Discovery Chemistry
Cancer Therapeutics
Translational Research

Reimagining Drug Discovery through Enabling Technology
data sciences/bioinformatics
engineering/automation
genomic technologies
data sciences/bioinformatics
engineering/automation
genomic technologies

Data Sciences/Bioinformatics
The data science and bioinformatics team is at the forefront of digital drug discovery techniques, pushing the potential for rapid scientific breakthroughs.

Engineering/Automation
Imagining what’s needed—even if it doesn’t exist yet—is a key ingredient for innovation.

Genomic Technologies
The mission of GNF’s Functional Genomics Group is to discover and validate new targets for therapeutic intervention and to identify the engagement targets or action mechanisms of therapeutic candidates derived from complex, phenotypic drug discovery campaigns.
ABOUT US